Kyverna Therapeutics (KYTX) Earnings Date & Reports
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
KYTX is expected to report earnings to rise 84.13% to -115 cents per share on November 18
Q3'26
Est.
$-1.16
Q2'26
Beat
by $0.45
Q1'26
Beat
by $0.38
Q4'25
Beat
by $0.21
Q3'25
Beat
by $0.17
The last earnings report on August 11 showed earnings per share of -62 cents, beating the estimate of -108 cents. With 417.41K shares outstanding, the current market capitalization sits at 421.77M.